Tissue Diagnostic Market 2019 Leading Companies Growth Dynamics, Technological Advancement and Product Innovations Rises Industry Share in Global Market till 2026
Tissue diagnosis is a diagnostic test which is used to detect the disease through biopsy, in which sample is taken out from the affected area or tumor for further diagnosis. A biopsy is mainly done to look for cancer detection or to detect rejection of transplanted organ draft. This test is basically performed to detect the nature of cells whether it is cancerous or non-cancerous tissue, which can be detected through CT-scan or x-rays. Biopsy tests can be classified as endoscopic biopsy, bone marrow biopsy, skin biopsy, kidney biopsy, liver biopsy, and prostate biopsy. It can be done by using needle biopsy, CT guided biopsy, ultrasound biopsy, and surgical biopsy for the tissue diagnostic. According to the American Journal of Nephrology, 2015, Australia has the highest numbers of annual renal biopsy rates (215 persons/million person/year) followed by Finland (176 persons/million person/year) and U.S. (175 persons/million person/year). The increased numbers of biopsy procedures likely to fuel the growth of the tissue diagnostic market, in the near future.
For More Information, Request sample copy of Business Report: https://www.coherentmarketinsights.com/insight/request-sample/1112
The growing prevalence of various cancer incidences is a major driving factor boosting the tissue diagnostic market. According to the American Cancer Society (ACS), 1.6 million new cases of cancer diagnosed in the U.S., in 2016. Moreover, growing research funding in cancer treatment and rising healthcare expenditure is likely to show a gradual rise in the tissue diagnostic market. National Cancer Institute, in 2015, spends US$ 4,480 million on various types of cancer research which includes breast cancer, colorectal cancer, cervical cancer, liver cancer, lung cancer, leukemia, ovarian cancer and uterine cancer.
Tissue diagnostic market taxonomy:
By Product Type:
- Tissue processors
- Slide warmers
- Paraffin dispenser
- Biological microscopes
- Embedded center modules
- Autopsy & dissection
- In situ hybridization
- Digital pathology
- Tissue microarray
- Special staining
- Breast cancer
- Lymphoma cancer
- Gastric cancer
- Prostate cancer
- Research laboratories
- Contract research organizations
Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/1112
Rise in the prevalence of cancer incidences to boost the tissue diagnostic market growth
According to the United States Cancer Statistics report published in 2014 by the Centers for Disease Control and Prevention (CDC), between 1999 and 2014, more than 1600 people a day, died due to the cause of cancer. Although screening tests help to detect cancer condition at an early stage, data from Healthy People 2020, an initiative from the Department of Health and Human Services, reveals that the screening rate is still below the national targets set. Combined data collected from CDC and National cancer institute (NCI) focus on the top 3 cancer incidences in males and females. In male prostate cancer the incidence rate is higher, whereas female’s breast cancer is popular in women, followed by lung and colon cancer respectively in both males and females.
New and advanced methods of tissue diagnosis favor the market growth
Advancement in tissue diagnostic process for the efficient diagnostic testing such as Fluorescence in situ hybridization (FISH), Immunohistochemistry (IHC) and In situ hybridization (ISH) opens the opportunity to grow tissue diagnostic markets in the future. In September 2017, researchers at the The University of Texas developed a new way of diagnosis by creating pen named as “MasSpec Pen”, which is handheld devices able to differentiate healthily tissue and tumor tissue in just 10 seconds, more than 150 times quicker than existing technology. This new tool provides improvement in cancer treatment and minimizes the risk of recurrence by offering precise diagnostic information, which eventually fuels the market growth of tissue diagnostic.
Key players operating in the tissue diagnostic market are Biocare Medical, Agilent technologies, Thermo Fisher Scientific, Sigma-Aldrich, Roche Diagnostics, Danaher corp., Biogenex Laboratories, Life Technologies, and Abbott laboratories.
To understand Research Methodology, please click https://www.coherentmarketinsights.com/ongoing-insight/tissue-diagnostic-market-1112About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
- CDN Newswire